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Urothelial bladder cancer is the second most common
tumor of the genitourinary tract. In Poland 3,500 new
cases of bladder cancer are diagnosed annually. Bladder
cancer develops more predominantly in males and
increases significantly in incidence between the ages of
60 and 70 years in the life. The risk factors for developing
bladder cancer are: cigarette smoking, exposure to aro-
matic amines, polycyclic aromatic hydrocarbons and
infection with Schistosoma haematobium. There is evi-
dence that some bladder cancers are a result of a genetic
predisposition to disease although up to now the genes of
the high penetrance to bladder cancer have not been
found. This situation calls for the development of innova-
tive therapies based on environmental features for blad-
der cancer prevention and control. One potential novel
approach is through diet. Some studies indicate that diet
modifications may prevent incidence of bladder cancer or
reduce the risk of recurrence or progression. Several epi-
demiologic evidence suggest that selenium concentration
is inversely related to risk of bladder cancer. A Finnish
cohort study found a protective effect for men but not
for women. An American nested case-control study
observed a statistically significant inverse association
between selenium toenail concentration and risk of blad-
der cancer in women but not in men. Some data are con-
flicting and did not find this association.
To validate the association between selenium concen-
trations and bladder cancer risk in Polish population we
have investigated 37 cases of bladder cancer and 37 con-
trols. In this analysis, a single control was selected for
each case, based on sex, year of birth (+/- 2 years) and
smoking status (+/- 20% pack-years). We conclude that
high selenium concentration shows the tendency to
decrease the risk of bladder cancer in the Polish popula-
tion (OR 2.1; 95%CI 0.5-7.9; p=0.33) but further
investigations are needed to achieve statistically signifi-
cant result.
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